Periodic Versus Continuous IV Iron Supplementation in HD Patients
Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to compare the efficacy of two regimens of intravenous iron
sucrose [continuous (in every hemodialysis session) versus intermittent (every 1-4 weeks)] on
the response of rHuEPO in the maintenance phase of its administration in hemodialysis
patients.